AH Bio Fund II, L.P. sold $11.8M of Nautilus Biotechnology (NAUT)

Executed Jun 2, disclosed Jun 4, 2 days later.

Value, as filed

$11.8M

5,000,000 sh across 2 lots

Executed

Jun 2

the trade date, as filed

Disclosed

Jun 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AP AH Bio Fund II, L.P. 10% owner profile →

AH Bio Fund II, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (1 purchase, 1 sale), most often in NAUT. Across 1 priced purchase filing, the average 21-session return was +73.4% from execution and +75.6% from disclosure (delay-adjusted; derived). The largest single filing was $11.8M of NAUT (5,000,000 sh across 2 lots, as filed), executed Jun 2.

The name

NAUT NAUT NAUT · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→